AU2003273969A1 - Sulfonamide derivatives as antipsychotic agents - Google Patents

Sulfonamide derivatives as antipsychotic agents

Info

Publication number
AU2003273969A1
AU2003273969A1 AU2003273969A AU2003273969A AU2003273969A1 AU 2003273969 A1 AU2003273969 A1 AU 2003273969A1 AU 2003273969 A AU2003273969 A AU 2003273969A AU 2003273969 A AU2003273969 A AU 2003273969A AU 2003273969 A1 AU2003273969 A1 AU 2003273969A1
Authority
AU
Australia
Prior art keywords
sub
sup
alkyl
cycloalkyl
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003273969A
Other languages
English (en)
Inventor
Ian Thomson Forbes
Andrew Derrick Gribble
Andrew P. Lightfoot
Andrew H. Payne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0223236A external-priority patent/GB0223236D0/en
Priority claimed from GB0223226A external-priority patent/GB0223226D0/en
Priority claimed from GB0314627A external-priority patent/GB0314627D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2003273969A1 publication Critical patent/AU2003273969A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Indole Compounds (AREA)
AU2003273969A 2002-10-07 2003-10-06 Sulfonamide derivatives as antipsychotic agents Abandoned AU2003273969A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0223236A GB0223236D0 (en) 2002-10-07 2002-10-07 Compouds
GB0223226.2 2002-10-07
GB0223226A GB0223226D0 (en) 2002-10-07 2002-10-07 Compounds
GB0223236.1 2002-10-07
GB0314627A GB0314627D0 (en) 2003-06-23 2003-06-23 Novel compounds
GB0314627.1 2003-06-23
PCT/EP2003/011174 WO2004031181A1 (en) 2002-10-07 2003-10-06 Sulfonamide derivatives as antipsychotic agents

Publications (1)

Publication Number Publication Date
AU2003273969A1 true AU2003273969A1 (en) 2004-04-23

Family

ID=32073912

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003273969A Abandoned AU2003273969A1 (en) 2002-10-07 2003-10-06 Sulfonamide derivatives as antipsychotic agents

Country Status (8)

Country Link
US (1) US7122538B2 (https=)
EP (1) EP1549639B1 (https=)
JP (1) JP2006504794A (https=)
AT (1) ATE327234T1 (https=)
AU (1) AU2003273969A1 (https=)
DE (1) DE60305519T2 (https=)
ES (1) ES2264003T3 (https=)
WO (1) WO2004031181A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050137186A1 (en) * 2003-12-18 2005-06-23 Abbott Gmbh & Co. Kg. Tetrahydrobenzazepines and their use
MXPA06006858A (es) * 2003-12-18 2006-09-04 Abbott Gmbh & Co Kg Tetrahidrobenzacepinas y su uso en la modulacion del receptor d3 de la dopamina.
US7799815B2 (en) 2005-08-22 2010-09-21 Glaxo Group Limited Triazole derivatives as modulators of dopamine D3 receptors
EP1837332A1 (en) * 2006-03-23 2007-09-26 Laboratorios Del Dr. Esteve, S.A. Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
US7897595B2 (en) 2006-05-26 2011-03-01 Forest Laboratories Holdings Limited Pyridoazepine derivatives
US20070293475A1 (en) * 2006-06-20 2007-12-20 Alcon Manufacturing Ltd. Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma
EP3569233A4 (en) 2017-01-13 2020-09-30 Sumitomo Dainippon Pharma Co., Ltd. THERAPEUTIC AGENT FOR NON-MOTOR SYMPTOMS ASSOCIATED WITH PARKINSON'S DISEASE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA792785B (en) 1978-07-07 1980-08-27 Smithkline Corp Mercapto substituted-2,3,4,5-tetrahydro-1h-3-benzazepines
GB9926302D0 (en) * 1999-11-05 2000-01-12 Smithkline Beecham Plc Novel compounds
WO2001045694A1 (en) 1999-12-21 2001-06-28 Smithkline Beecham Corporation Urotensin-ii receptor antagonists
DE10053799A1 (de) 2000-10-30 2002-05-08 Bayer Ag Verwendung von Tetrahydroisochinolinsulfonamiden
MXPA04007920A (es) 2002-02-13 2004-11-26 Glaxo Group Ltd Derivados de bencensulfonamida como agentes antisicoticos.

Also Published As

Publication number Publication date
US7122538B2 (en) 2006-10-17
ES2264003T3 (es) 2006-12-16
EP1549639B1 (en) 2006-05-24
US20060063757A1 (en) 2006-03-23
JP2006504794A (ja) 2006-02-09
ATE327234T1 (de) 2006-06-15
WO2004031181A1 (en) 2004-04-15
DE60305519D1 (de) 2006-06-29
DE60305519T2 (de) 2006-11-23
EP1549639A1 (en) 2005-07-06

Similar Documents

Publication Publication Date Title
DK1029853T3 (da) Heteroaromatiske bicykliske derivativer, der er egnede som anticancermidler
AU2001235844A1 (en) Imidazol-2-carboxamide derivatives as raf kinase inhibitors
WO2004112710A3 (en) COMPOSITIONS AND METHODS FOR INHIBITING TGF-ß
WO2006067614A3 (en) Heteroaromatic derivatives useful as anticancer agents
NO20082101L (no) Pyrido-, pyrazo- og pyrimido-pyrimidinderivater som mTor inhibitorer
MY139446A (en) Novel quinoline derivatives
EA200500174A1 (ru) Новые производные бензимидазола, полезные в качестве антипролиферативных агентов
BR0315405A (pt) Compostos inibidores da integrase tricìclica pré-organizados
DE60027648D1 (de) Sulfonamide enthaltende indolderivate
GB0114286D0 (en) Nucleoside Derivatives
WO2006049835A3 (en) Indole and benzimidazole derivatives
WO2003082205A3 (en) Compounds and methods
DE602006011752D1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
DK1643984T3 (da) Anvendelse af parthenolidderivater som antileukæmiske og cytotoksske midler
MX2007005155A (es) Nuevos derivados de aminopiridina que tienen accion inhibidora selectiva de la aurora a.
PL373397A1 (en) Arylsulfonyl derivatives with 5-ht6 receptor affinity
PL353646A1 (en) Aminobenzophenones as inhibitors of il-1beta and tnf-alpha
MY138826A (en) 2,7-substituted indoles
ATE429429T1 (de) Pharmazeutisches verfahren und damit hergestellte verbindungen
DE60206505D1 (de) Substituierte benzopyran derivate gegen arrhythmie
EP1277744A4 (en) OXADIAZONE DERIVATIVES WITH ANTIBODY EFFECT
AU2003273969A1 (en) Sulfonamide derivatives as antipsychotic agents
WO2004067703A3 (en) 5ht7 antagonists and inverse agonists
CA2535210A1 (en) Novel farnesyl protein transferase inhibitors as antitumor agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase